Montrouge, France, September 5, 2023
DBV Technologies to Participate in Upcoming Investor Conference
DBV Technologies (OTC:DBVTF), a clinical-stage biopharmaceutical company, today announced the company will participate in the H.C. Wainwright Annual Global Investment Conference taking place on September 11th ?13th in New York, NY. Daniel Tassé, Chief Executive Officer, will represent the company in a fireside chat session on Tuesday, September 12th at 4:00 pm EST, as well as one-on-one investor meetings throughout the day.
A live webcast of the presentation will be available on the Investors & Media section ...